Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial

Authors:

Abstract
No abstract available
Funding Information
  • Aeras
  • FDA
  • Bill and Melinda Gates Foundation
  • Aeras
  • FDA (5U18FD004012)
  • Bill and Melinda Gates Foundation (OPP1066660)

This publication has 30 references indexed in Scilit: